The regulatory mechanism for the CERT-VAP interaction
Project/Area Number |
23790118
|
Research Category |
Grant-in-Aid for Young Scientists (B)
|
Allocation Type | Multi-year Fund |
Research Field |
Biological pharmacy
|
Research Institution | National Institute of Infectious Diseases |
Principal Investigator |
KUMAGAI Keigo 国立感染症研究所, 細胞化学部, 主任研究官 (40443105)
|
Co-Investigator(Renkei-kenkyūsha) |
HANADA Kentaro 国立感染症研究所, 細胞化学部, 部長 (30192701)
|
Project Period (FY) |
2011 – 2012
|
Project Status |
Completed (Fiscal Year 2012)
|
Budget Amount *help |
¥4,290,000 (Direct Cost: ¥3,300,000、Indirect Cost: ¥990,000)
Fiscal Year 2012: ¥2,340,000 (Direct Cost: ¥1,800,000、Indirect Cost: ¥540,000)
Fiscal Year 2011: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
|
Keywords | セラミド / スフィンゴミエリン / CERT / VAP / FFATモチーフ / リン酸化 / 脂質輸送 |
Research Abstract |
CERT is a cytosolic protein that transports ceramide from the endoplasmic reticulum to the Golgi apparatus. The CERT-mediated transport of ceramide is accelerated by interaction between CERT and ER-resident membrane protein, VAP-A, but a regulatory mechanism for the interaction has not been determined. In this study, we demonstrated that phosphorylation at certain residue of CERT strengthened the interaction between CERT and VAP-A to facilitate ER-to-Golgi ceramide trafficking by CERT.
|
Report
(3 results)
Research Products
(7 results)